Cleared Traditional

K212626 - PathBuilder Transseptal Guiding Introducer

K212626 is an FDA 510(k) clearance for PathBuilder Transseptal Guiding Introducer, manufactured by Shanghai Microport EP Medtech Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DYB cleared through the Traditional 510(k) pathway after a 217-day FDA review.

K212626 · Shanghai Microport EP Medtech Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2022
Decision
217d
Days
Class 2
Risk

K212626 is an FDA 510(k) clearance for the PathBuilder Transseptal Guiding Introducer. Classified as Introducer, Catheter (product code DYB), Class II - Special Controls.

Submitted by Shanghai Microport EP Medtech Co., Ltd. (Shanghai, CN). The FDA issued a Cleared decision on March 23, 2022 after a review of 217 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Shanghai Microport EP Medtech Co., Ltd. devices

FDA 510(k) Submission Details - K212626

510(k) Number K212626 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 2021
Decision Date March 23, 2022
Days to Decision 217 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
92d slower than avg
Panel avg: 125d · This submission: 217d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DYB Device Classification - Class 2, Special Controls

Product Code DYB Introducer, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DYB Introducer, Catheter

All 432
Devices cleared under the same product code (DYB) and FDA review panel - the closest regulatory comparables to K212626.
EXTesia Introducer Sheath Set
K220604 · Curatia Medical Co. · Apr 2022
Intri24 Sheath
K212392 · Inari Medical, Inc. · Apr 2022
Dib UltraNav Transseptal Catheter System
K213492 · Dib Ultranav Medical, LLC · Mar 2022
PathBuilder Steerable Introducer
K211530 · Shanghai Microport EP Medtech Co., Ltd. · Feb 2022
AcQCross Qx Integrated Transseptal Dilator/Needle
K220047 · Acutus Medical, Inc. · Feb 2022
Prelude IDeal 9F Hydrophilic Sheath Introducer
K212152 · Merit Medical Systems · Jan 2022